Brussels, Brussels-Capital, Belgium · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Commercial Strategy, P&L Management, Oncology Drug Launch, Market Access, Pricing Strategy
Redwood City, California, United States · Hybrid
$186k–$233k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Healthcare Compliance, Compliance Operations, Process Design, Workflow Optimization, Project Management
Basel, Basel-City, Switzerland · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Regulatory Affairs, Labelling, Oncology, EU Regulations, EMA
Redwood City, California, United States · Hybrid
$129k–$160k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Legal Operations, Process Improvement, Vendor Management, Project Management, Legal Technology
Redwood City, California, United States · Hybrid
$186k–$233k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Change Management, Project Management, Clinical Development Process, Stakeholder Management, Business Operations
Amsterdam, North Holland, Netherlands · Remote OK
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: KOL Engagement, Scientific Communication, Oncology Expertise, Clinical Research Methodologies, Drug Development
Vienna, Austria · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Market Access Strategy, Pricing and Reimbursement, Health Technology Assessment, Stakeholder Management, Oncology
Germany · Remote OK
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Oncology Product Sales, Strategic Account Management, Product Launch, Oral Oncolytics, Companion Diagnostics
Basel, Basel-City, Switzerland · Remote OK
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Healthcare Compliance, People Management, Risk-Based Analysis, Regulatory Compliance, Pharmaceutical Commercialization
Redwood City, California, United States · Hybrid
$244k–$305k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Clinical Operations, Vendor Management, Contract Negotiation, Budget Development, Oncology Drug Development
Redwood City, California, United States · Hybrid
$186k–$233k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: EH&S Program Management, Regulatory Compliance, Incident Investigation, Root Cause Analysis, Business Continuity Planning
Redwood City, California, United States · Hybrid
$164k–$205k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Stability Management, Analytical Development, GMP Regulations, ICH Guidelines, Contract Organization Management
Redwood City, California, United States · Hybrid
$265k–$331k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Procurement Strategy, Strategic Sourcing, Supplier Management, Procurement Operations, Governance
Redwood City, California, United States · Remote OK
$244k–$305k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Medical Affairs Strategy, Scientific Content Development, Training Program Design, Oncology Expertise, Cross-Functional Leadership
Redwood City, California, United States · Remote OK
$211k–$264k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Strategic Pricing, Market Access, Oncology Pricing Strategy, Gross-to-Net Forecasting, Payer Contracting
Redwood City, California, United States · Remote OK
$244k–$305k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Global Pricing Strategy, Market Access, Health Technology Assessment (HTA), Oncology Product Development, Value Proposition Development
Redwood City, California, United States · Hybrid
$164k–$205k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Computer System Validation, Computer Software Assurance, GxP Compliance, FDA 21 CFR Part 11, EU Annex 11
Redwood City, California, United States · Remote OK
$244k–$305k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Transaction Leadership, Deal Structuring, Negotiation, Business Development, Valuation Analysis
Redwood City, California, United States · Remote OK
$244k–$305k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Search And Evaluation, Business Development, Due Diligence, Precision Oncology, Portfolio Strategy
Poland · Remote OK
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Country Management, Oncology Drug Launch, P&L Management, Market Access Strategy, Pricing Strategy
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
Lead the commercial and operational expansion of Revolution Medicines in Belgium and Luxembourg, including P&L management and country operations. Develop and execute pre-launch and commercialization plans for oncology therapies while ensuring local regulatory compliance.
Requires an advanced degree and at least 15 years of biopharmaceutical leadership experience in oncology, specifically with drug launches in Belgium and Luxembourg. Must be fluent in English and the local language with a proven track record of building high-performing teams.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
Reporting to the Vice President, General Manager, Mid-Sized Markets of Europe, the Country Manager, Belgium&Luxemburg will lead the expansion efforts critical to maximizing the opportunity for Revolution Medicines (RevMed) innovation to help patients. In collaboration with the regional leadership team, the successful individual will develop and implement commercial and operational strategy to accelerate the engagement with key stakeholders and customers in Belgium&Luxemburg. The incumbent will be responsible for developing pre-launch and commercialization plans for Belgium&Luxemburg and providing input into lifecycle plans across the RevMed portfolio. This individual will also be responsible for Belgium&Luxemburg’s P&L, country operations and will ensure compliance requirements are met locally.
Responsibilities:
Develop and execute comprehensive plans for the company’s expansion in Belgium&Luxemburg.
Develop and manage the P&L in Belgium&Luxemburg including the budget for operations, ensuring optimal resource allocation.
Build and lead the country team in Belgium&Luxemburg, working with corporate functional leaders to ensure that each team member and business function execute against the clear and well-aligned business objectives.
Lead the planning and execution of product launches in Belgium&Luxemburg including PEL, market access strategies, pricing, and marketing strategy, and where appropriate, early access programs.
Evaluate the competitive environment and understand the profile of portfolio and identify opportunities and challenges in the market.
Set key launch and financial performance metrics including revenue, profitability etc.
Drive and implement country-specific development plans in Belgium&Luxemburg, including appropriate site selection, quality and enrollment in-line with regulatory/compliance requirements.
Co-lead with Finance, Legal, and Commercial, the selection and contract negotiation with any local distributor, and be accountable for successful execution and achievement of goals by the distributor.
Establish commercial processes, governance, and ways of working as part of the country build-out in Belgium&Luxemburg.
Establish country governance, risk management, and compliance framework and SOPs.
Ensure all activities comply with local regulations and internal company policies.
Advanced degree in life sciences, business administration, or a related field.
Minimum 15 years of proven experience in leadership roles within the biopharmaceutical industry in the field of oncology required.
Experience of drug launch in oncology in Belgium&Luxemburg is mandatory.
In-depth knowledge of pharmaceutical market in Belgium&Luxemburg, access, pricing and regulatory environment.
Previous country manager experience in Belgium&Luxemburg is required.
Proven track record shaping and executing country strategy.
Proven experience building and developing a high performing cross-functional team is a must.
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial commercial environment.
In depth knowledge of approval and early access mechanisms of products in Belgium&Luxemburg.
Fluency in both verbal and written English and local language required.
Ability to create and nurture a strong culture of collaboration and authenticity to extend and replicate the RevMed culture.
Proven success in building effective relationships with internal stakeholders, regional authorities, and vendors.
Highly organized and motivated individual possessing excellent communication, presentation and interpersonal skills.
Strong leadership and influencing skills with the ability to create a clear sense of direction.
Thrives in a fast-paced, dynamic small company environment and able to roll out the sleeves to get things done.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
#LI-Hybrid #LI-LO1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Revolution Medicine enables physicians to integrate personalized medicine into their practices in order to more effectively treat patients. Our genes play an important role in determining how we respond to about 75% of prescription drugs. Scientific research has demonstrated which genes predict these responses. According to the American Medical Association (AMA), 98% of physicians agree that knowing a patient’s genetic profile would help in prescribing medications. Yet, 90% of physicians do not feel they are adequately informed about how to apply genetic testing to treatment decisions. Our mission is to improve the quality of patient care by helping doctors determine optimal treatment strategies and more accurately predict treatment responses. Revolution Medicine has developed ScriptMatch, an analytical process that enables physicians to easily incorporate genetic testing into their practices. Our company solves a major issue in the clinical market and addresses an emerging trend in patient-driven healthcare: having clinical results that become part of the medical record and applicable to future treatments.
View all jobs at Revolution MedicineRevolution Medicine enables physicians to integrate personalized medicine into their practices in order to more effectively treat patients. Our genes play an important role in determining how we respond to about 75% of prescription drugs. Scientific research has demonstrated which genes predict these responses. According to the American Medical Association (AMA), 98% of physicians agree that knowing a patient’s genetic profile would help in prescribing medications. Yet, 90% of physicians do not feel they are adequately informed about how to apply genetic testing to treatment decisions. Our mission is to improve the quality of patient care by helping doctors determine optimal treatment strategies and more accurately predict treatment responses. Revolution Medicine has developed ScriptMatch, an analytical process that enables physicians to easily incorporate genetic testing into their practices. Our company solves a major issue in the clinical market and addresses an emerging trend in patient-driven healthcare: having clinical results that become part of the medical record and applicable to future treatments.
View all jobs at Revolution Medicine